recoveriXFranchise Cost, Revenue & Review 2026
Data from FDD filing
FranchiseVerdict summary · 2026
A recoveriX franchise requires a total initial investment of $72K – $353K, including a $10K franchise fee and an ongoing 11.0% royalty[2]. The 2025 FDD does not disclose unit-level revenue (no Item 19). Verdict grade: B. Run a live ROI scan →
Data last verified June 18, 2026 · figures per the 2025 FDD issuance
Overview
- Investment
- $72K – $353K
- 11th pct Healthcare
- Avg gross sales
- N/A
- 48th pct Healthcare
- Royalty
- 11.0%
- 53rd pct Healthcare
- Units
- 0
- 0th pct Healthcare
- SBA default
- N/A
Quick verdict · Healthcare · color = vs category peers
Green = >15% above Healthcare avg · No shading = within ±15% · Red = >15% below avg · Source: FDD filings + SBA 7(a)
Data from public FDD filings and SBA records. Not financial advice. Methodology
Started franchising in 2023. Newer systems carry more uncertainty but may offer better territories.
The franchisor's auditor raised doubt about continued operations. This is a serious risk signal.
Bottom line
- Total investment $72K – $353K including a $10K franchise fee, 11.0% ongoing royalty.
- No Item 19 financial performance data disclosed. The franchisor chose not to publish revenue figures.
- Verdict B (Above Average) with a risk score of 58/100.
- Auditor disclosed a going-concern note, which flagged doubt about the franchisor's ability to continue operations. Verify against the latest FDD.
Item 1 · who you're contracting with
The Franchisor
- Legal entity
- G.TEC NEUROTECHNOLOGY USA, INC.
- Parent company
- g.tec medical engineering GmbH
- CEO title
- Chief Executive Officer
- Christoph Guger
- CEO experience
- 25 yrs
- Years in role or industry
- Founder active
- Yes
- Original founder still leading the business
- Incorporated in
- DE
- HQ
- 1580 Columbia Turnpike, Building 2, Suite 1, Castleton-on-Hudson, New York 12033
- Auditor
- Metwally CPA PLLC
- Audited financials
- Franchisor revenue
- $1.4M
- vs $1.4M prior year
- ⚠ Going-concern note
- Disclosed in FDD 2025
- Auditor flagged doubt about continued operations. Verify against the latest FDD before deciding.
Overview
About
recoveriX franchisees operate rehabilitation/recovery therapy clinics, likely specializing in technology-assisted or specialized recovery protocols. Day-to-day operations involve patient/client treatment delivery, equipment management, clinical staff supervision, insurance billing, and marketing to build local client bases in protected territories.
- CEO
- Christoph Guger
- Headquarters
- NY
- Founded
- 2014
- FDD year
- 2025
- States available
- 0
FDD Item 7 · 2025 filing · 13 line items
Initial investment breakdown
| Line item | Low | High | |
|---|---|---|---|
| Initial Franchise Feenot refundable | $10K | $10K | |
| Construction and Leasehold Improvements | $0 | $5K | |
| Lease Deposits | $0 | $20K | |
| Furniture, Fixtures and Equipment | $11K | $53K | |
| Signage | $500 | $5K | |
| Grand Opening Marketing Expenses | $1K | $10K | |
| Computer, Software, and Business Management System | $0 | $3K | |
| Utility Deposits | $0 | $5K | |
| Insurance Deposits | $15K | $75K | |
| Travel for Initial Training | $2K | $5K | |
| Professional Fees | $3K | $10K | |
| Licenses and Permits | $0 | $2K | |
| Additional Funds - Three Months | $30K | $150K | |
| Total initial investment | $72K | $353K |
Line items extracted from FDD Item 7. Ranges reflect the franchisor's stated low and high per line. Total is the sum of line-item lows / highs — actual costs may fall outside this range depending on market and build-out scope.
Item 7 · what it costs to open + operate
The Vitals
- Total investment
- $72K – $353K
- Better than avg vs category
- Liquid capital req'd
- $30K – $150K
- Near category avg vs category
- Franchise fee
- $10K – $10K
- Better than avg vs category
- Royalty
- 11.0%
- percentage_of_gross · typical 6–8%
- Ad fund
- Up to $500 per month
- Total fee load
- 11.0%
- vs 9–13% typical
Ongoing fees · Item 6
| Fee | Amount |
|---|---|
| Royalty | 11.0% of gross sales |
| Technology fee | $500 |
| Training fee | $800 |
| Transfer fee | $5K |
| Renewal fee | $3K |
| Total fee load | 11.0% of rev |
Financial Performance
This franchisor did not disclose financial performance representations in Item 19, or our extractor could not parse them.
vs Healthcare averages
How recoveriX Compares
Unit growth
Item 20 · unit dynamics
The Growth Chart
- Total units
- 0
- Opened
- 0
- Last reporting year
- Closed
- 0
- Terminated
- 0
- Franchisor ended the franchise (per Item 20)
- Non-renewed
- 0
- Term expired, not renewed (per Item 20)
- Company-owned
- 0
- Corporate units in the system
- Multi-unit owners
- 66.7%
3-year detail · Item 20
- Transfers (3yr)
- 0
- Projected new
- 1
- Franchisor's next-year forecast
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
SBA loan performance
Government records
SBA Loan Data
Aggregated from SBA 7(a) and 504 loan disclosures, public data unique to FranchiseVerdict.
No SBA loan data available for this brand.
Risk analysis
FranchiseVerdict rating + FDD Items 3, 5, 6, 12, 17
Risk & Legal
recoveriX presents elevated risk due to complete absence of operating unit data, undisclosed financial performance metrics, and a going concern status in a pre-revenue franchise system with above-market royalties.
Litigation (Item 3)
No litigation required to be disclosed
Bankruptcy (Item 4)
None disclosed
Audited financials (Item 21)
Yes · Metwally CPA PLLC⚠ Going-concern note flagged
Franchisor revenue (Item 21)
Franchisor entity revenue (not unit-level)
Supplier relationship · Items 8 & 16
- Franchisor sells you products: Yes
- Kickbacks from required suppliers: No
- Must buy proprietary products: Yes
- Restricted to system-approved products: Yes
- Can negotiate own supplier terms: No
Score breakdown · what drove the 58 / 100 rating
- 01MEDZero disclosed franchise units with unknown growth trajectory indicates either brand-new system or undisclosed contraction
- 02MEDNo average revenue or net income disclosure (missing Item 19) prevents ROI validation against $72K-$352.5K investment range
- 03MINOR11% royalty rate is above-market for wellness/therapy franchises, reducing margins without proven unit economics
- 04MINORWide investment range ($280.5K spread) suggests inconsistent startup costs or undefined territory/build-out standards
- 05HIGHGoing Concern status with zero operating units raises sustainability and franchisor financial stability questions
- 06MINOR5-year term is shorter than industry standard (10 years), indicating higher renewal/renegotiation risk
Severity inferred from the FDD text · not a regulatory classification
FDD Items 5, 6, 12, 17 · continued from Risk & Legal
Contract & Territory Detail
| Initial term | 5 years |
|---|---|
| Renewal term | 5 years |
| Allowed renewalsℹ | 1 |
| Territory type | Radius and Population |
| Protected territory | Yes |
| Exclusive territoryℹ | No |
| Territory radius | 1 mi |
| Territory population | 250,000 |
| Online sales rights | Restricted |
| Franchisor can compete | Yes |
| Hire a manager? | Allowed |
| Owner-operator | Optional |
| Non-compete (years)ℹ | 2 years |
| Non-compete (miles)ℹ | 25 mi |
| Right of first refusalℹ | Yes |
| Transfer requires consent | Yes |
| Termination notice | 30 days |
| Mandatory arbitration | Yes |
| Arbitration location | Rensselaer County, New York |
| Jury trial waiver | Yes |
| Governing law | New York |
| Litigation count | 0 |
View Item 3 litigation summary
No litigation required to be disclosed
Items 10, 11
Training & Operations
- Classroom training
- 14 hrs
- On-the-job training
- 10 hrs
- Training location
- Schiedlberg, Austria
Items 5 & 11
Franchisor Support
Frequently asked questions
Frequently Asked Questions
How much does it cost to open a recoveriX franchise?
The total investment to open a recoveriX franchise ranges from $72K – $353K, with an initial franchise fee of $10K. This includes real estate, equipment, inventory, and working capital as disclosed in their Franchise Disclosure Document (FDD).
What do recoveriX franchise owners earn?
recoveriX does not disclose average franchise owner earnings in their FDD Item 19. Not all franchisors are required to make financial performance representations. We recommend asking existing franchisees directly about their financial experience.
What is recoveriX's franchise failure rate?
SBA 7(a) loan charge-off data is not available for recoveriX (fewer than 10 loans on file). Charge-off rates are one way to gauge franchise risk, but not all franchise loans go through the SBA program. We recommend reviewing turnover and closure data in the FDD and speaking with current franchisees.
Is recoveriX a good franchise to buy?
FranchiseVerdict rates recoveriX as a B-grade franchise with a risk score of 58 out of 100, based on our analysis of investment costs, revenue data, SBA loan performance, and growth trends. Our rating is based solely on publicly available FDD and government data; we recommend speaking with current franchisees before making any investment decision. This is not investment advice.
Data sourced from public FDD filings and SBA 7(a) FOIA records. Not financial advice.
For franchisors
Are you the franchisor?
If you represent recoveriX, you can request corrections or provide updated information.
Claim this brandOther Healthcare franchises
Compare similar franchise opportunities in the Healthcare category
Data extracted from public FDD filings and SBA 7(a) loan disclosures (FOIA). This information is provided for research purposes only and does not constitute financial, legal, or investment advice. Verify all figures with the franchisor's current Franchise Disclosure Document before making any investment decision.